Jan Ankjaer Jensen

Medimaps is a Swiss company that provides advanced medical deep-tech and AI imaging software for comprehensive bone microarchitecture assessment. This is a crucial aspect of bone strength and is essential for evaluating bone health to prevent fracture. The company was founded by medical practitioners and clinical researchers with the goal to transform complex clinical needs into straightforward routine solutions that seamlessly integrate the healthcare professionals’ workflow. Medimaps revolutionized the bone health market with Trabecular Bone Score which provides clinicians with additional, valuable insights into bone quality and fracture risk from existing scans. ​ Medimaps’ flagship product, TBS Osteo, powered by TBS insight AI-ready technology, has been widely adopted for clinical use in 90 countries and more than 4.5 million procedures are performed every year. In January 2022, TBS Osteo achieved a significant milestone by being approved for reimbursement by Medicare in the USA under Category 1, which indicates that the procedure meets strict criteria for clinical acceptance, efficacy and widely use. Medimaps Group, headquartered in Geneva, Switzerland, has offices in the United States and France. Its U.S. affiliate, Medimaps Group USA LLC, markets the company products and services.

Copenhagen-based clothing-tech company on a mission to reengineer the clothing industry for the planet and people. Certified B Corp.

We augment Radiology through AI & machine learning focusing on MSK X-Ray analysis. We are on a mission to ensure every patient receives affordable, accessible, expert level diagnosis by building technology that augments and eventually automates reading of x-ray images. All while lowering the radiologist dependency.

Passendo is the first dedicated email ad server built for publishers who want full control, better performance, and smarter monetization. From global media giants to niche newsletters, publishers trust Passendo to turn email ads into a consistent and scalable revenue stream. We empower publishing teams to: 🟣 Serve native, responsive, and dynamic email ads 🟣 Run direct and programmatic campaigns side by side 🟣 Improve targeting with first-party data and smart segmentation 🟣 Unlock new revenue streams with flexible formats and pricing models 🟣 Gain full control over ad placement, pacing, and frequency 🟣 Get real-time insights with reliable reporting 🟣 Integrate seamlessly with your ESP, OMS, and DSP 🟣 Automate workflows without compromising on quality or performance Our platform is privacy-first, fully customizable, and built for teams that care about performance and user experience in equal measure. And we’re not stopping there. We’ve developed our own DSP, giving you access to premium demand without relying on third-party platforms. And we’ve launched The Monetization Club – a curated community where forward-thinking publishers unlock new opportunities together. Email ad serving – solved.

We are on a mission to ensure timely detection of a hidden and potentially fatal chronic liver disease that one in four have without knowing it. We give people a chance to change course before it is too late. Something that is not given today. At Evido, we are fighting the global liver pandemic that Fatty Liver Disease represents. It is referred to as the new diabetes and kills more than one million people every year. Today, we lack accurate ways of detecting at-risk people in time, which leads to three out of four, not being diagnosed before it is too late. Evido is founded and anchored in years of extensive clinical research and high quality health data. We are introducing new data driven solutions to timely detect at-risk people and close a crucial gap in the field of Fatty Liver Disease.

ART OF CRIME - SPECIALISED IN DEVELOPING ENGAGING WACKY INTERACTIVE GAMES FOR KIDS OF ALL AGES We offer the freedom of socialization (hanging out with peers) whist reading and participating in fun stories with extra-ordinary characters in a safe moderated environment. Our basic game play is free with a subscription/topup model for those who want a more full gaming experience. The team behind the concept is vast and has been driven to this point by our need, belief and challenge to produce an online experience that the audience (not only) finds marvelous, but also harbors educational and developmental values. The opportunity to connect these values as an undertone to excellent game play and storyline development is really exciting.

Medimaps is a Swiss company that provides advanced medical deep-tech and AI imaging software for comprehensive bone microarchitecture assessment. This is a crucial aspect of bone strength and is essential for evaluating bone health to prevent fracture. The company was founded by medical practitioners and clinical researchers with the goal to transform complex clinical needs into straightforward routine solutions that seamlessly integrate the healthcare professionals’ workflow. Medimaps revolutionized the bone health market with Trabecular Bone Score which provides clinicians with additional, valuable insights into bone quality and fracture risk from existing scans. ​ Medimaps’ flagship product, TBS Osteo, powered by TBS insight AI-ready technology, has been widely adopted for clinical use in 90 countries and more than 4.5 million procedures are performed every year. In January 2022, TBS Osteo achieved a significant milestone by being approved for reimbursement by Medicare in the USA under Category 1, which indicates that the procedure meets strict criteria for clinical acceptance, efficacy and widely use. Medimaps Group, headquartered in Geneva, Switzerland, has offices in the United States and France. Its U.S. affiliate, Medimaps Group USA LLC, markets the company products and services.

Copenhagen-based clothing-tech company on a mission to reengineer the clothing industry for the planet and people. Certified B Corp.

We augment Radiology through AI & machine learning focusing on MSK X-Ray analysis. We are on a mission to ensure every patient receives affordable, accessible, expert level diagnosis by building technology that augments and eventually automates reading of x-ray images. All while lowering the radiologist dependency.

Passendo is the first dedicated email ad server built for publishers who want full control, better performance, and smarter monetization. From global media giants to niche newsletters, publishers trust Passendo to turn email ads into a consistent and scalable revenue stream. We empower publishing teams to: 🟣 Serve native, responsive, and dynamic email ads 🟣 Run direct and programmatic campaigns side by side 🟣 Improve targeting with first-party data and smart segmentation 🟣 Unlock new revenue streams with flexible formats and pricing models 🟣 Gain full control over ad placement, pacing, and frequency 🟣 Get real-time insights with reliable reporting 🟣 Integrate seamlessly with your ESP, OMS, and DSP 🟣 Automate workflows without compromising on quality or performance Our platform is privacy-first, fully customizable, and built for teams that care about performance and user experience in equal measure. And we’re not stopping there. We’ve developed our own DSP, giving you access to premium demand without relying on third-party platforms. And we’ve launched The Monetization Club – a curated community where forward-thinking publishers unlock new opportunities together. Email ad serving – solved.

We help entrepreneurs succeed. It has been our mission from day one. We challenge existing paradigms of how things are done in the normal VC world. Our experience of actually being in the thick of the action day in, day out with Founders and their companies, actively pushing them towards their end game - wherever it might be - has taught us it pays off. To be active. To be present. To be hands on.